C12N 2770/34011
Potyviridae
C12N2770/34011 (Potyviridae) appears on 40 US grants and 34 published applications in this corpus.
Search patents in C12N- Granted patents
- 40
- Published applications
- 34
- Assignees
- 36
- Inventors
- 139
- Latest grant
- 13 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 5 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 6 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 2 |
| 2003 | 0 | 3 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 3 | 2 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 3 |
| 2012 | 3 | 0 |
| 2013 | 2 | 4 |
| 2014 | 1 | 0 |
| 2015 | 0 | 2 |
| 2016 | 1 | 3 |
| 2017 | 3 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 2 |
| 2020 | 0 | 0 |
| 2021 | 1 | 2 |
| 2022 | 1 | 2 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 2 | 2 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2770/34022New viral proteins or individual genes, new structural or functional aspects ofIndexing code35
- C12N 2770/34041Use of virus, viral particle or viral elements as a vectorIndexing code6
- C12N 2770/34023Virus like particles [vlp]Indexing code5
- C12N 2770/34033Use of viral protein as therapeutic agent other than vaccineIndexing code2
- C12N 2770/34021Viruses as suchIndexing code1
- C12N 2770/34031Uses of virus other than therapeutic or vaccineIndexing code1
- C12N 2770/34071Demonstrated in vivo effectIndexing code1
- C12N 2770/34032Use of virus as therapeutic agent, other than vaccineIndexing code0
Recent patents
- Method for robust control of gene expression13 May 2025US 12,297,236 B2California Institute of Technology
- Selective cell death-inducing enzyme system4 Feb 2025US 12,214,011 B2
- Method for robust control of gene expression21 Nov 2023US 11,820,794 B2California Institute of Technology
- Sugarcane mosaic virus as a transient gene expression vector1 Mar 2022US 11,261,455 B2Iowa State University Research Foundation, Inc.
- Fluorescence amplification method for forward genetic discovery of factors in human mRNA degradation13 Jul 2021US 11,060,153 B2Yale University
- System for regulating protein translation13 Aug 2026US 2026/0234645 A1National University Corporation Tokyo Medical and Dental University
- System For Modulating Receptor Tyrosine Kinase Signaling And Methods Of Use Thereof9 Jul 2026US 2026/0193634 A1The Johns Hopkins University
- Method for robust control of gene expression28 Aug 2025US 2025/0270262 A1California Institute of Technology
- Mutant proteases and uses thereof16 Jan 2025US 2025/0019740 A1Board of Regents, The University of Texas System
- Method for robust control of gene expression16 May 2024US 2024/0158449 A1California Institute of Technology
Most cited
By later US patents
- Plant potyvirus expression vector with a gene for protease94US 5,162,601 AThe Upjohn Company · 1992
- Transgenic plants expressing DNA constructs containing a plurality of genes to impart virus resistance89US 6,337,431 B12002
- Production of virus resistant plants88US 5,583,021 AState of Oregon acting by and through the State Board of Higher Education on behalf of Oregon State University · 1996
- Ribonuclease resistant RNA preparation and utilization80US 5,939,262 AAmbion, Inc. · 1999
- DNA comprising plum pox virus and tomato spotted wilt virus cDNAS for disease resistance23US 5,569,823 ABayer Aktiengesellschaft · 1996